Health Care Counsel

Arent Fox's health care law blog offers news, analysis, and insights for the health care industry.

Health Care Counsel

Erin E. Atkins

Erin E. Atkins, Associate at Arent Fox
Erin E. Atkins
Associate
Washington, DC
202.828.3436

Erin Atkins is an associate in the firm’s Health Care practice. She advises a variety of clients (such as long term care providers, suppliers, pharmacies, pharmaceutical manufacturers and others in the health care industry) on statutory and regulatory compliance, reimbursement, and transactional issues related to the Medicare, 340B, and Medicaid programs, in addition to corollary state law issues. Erin also provides clients with fraud and abuse counseling under the federal anti-kickback statute.

Client Work

Erin’s clients include health care providers (including long term care providers, home health and hospice agencies, and pharmacies), pharmaceutical and device manufacturers, payors, hospital systems, and DMEPOS suppliers. She assists her clients not only with health care regulatory issues, but also transactional services, such as review, negotiation, and preparation of health care related contracts and agreements. Erin manages transactional due diligence reviews and analysis for health care acquisitions, mergers, and changes of ownership.

Previous Work

Prior to joining Arent Fox, Erin was an associate at several international law firms, where she practiced in health care and life sciences. Prior to her career as a health care attorney, Erin’s practice was focused on capital markets, commercial real estate, and global finance.

Professional Activities

Erin is a member of the American Health Lawyers Association, and the Health Law Sections of both the District of Columbia Bar Association and the North Carolina Bar Association. Erin is also a member of the National Association of Women Lawyers.

 

Blog Posts by Erin E. Atkins

Prescription Drug Pricing & Government Price Reporting
alert
Pharma Industry Take Note: Maryland Passed Price-Gouging Prohibition
Alleged price gouging by drug manufacturers and distributors has been in the news the past several years, causing many lawmakers to threaten to take action. Maryland has become the first state to do so – on May 26, 2017, Governor Larry Hogan of Maryland informed the Maryland Speaker of the House that he would permit H.B. 631, also known as the “Prohibition Against Price Gouging for Essential Off-Patent or Generic Drugs”(437th Gen. Assemb., Reg. Sess. (Md. 2017)) to become law. The Act takes effect October 1, 2017, and makes Maryland the first state in the nation to prohibit “price gouging” by manufacturers or wholesale distributors of generic prescription drugs. Of note, Governor Hogan did not sign the bill into law, rather he decided not to veto it, rendering the bill law after 30 days.
 
Continue Reading →
Prescription Drug Pricing & Government Price Reporting
alert
Reminder to Generic Manufacturers: Q1 2017 Unit Rebate Amounts Billed by State Medicaid Programs Will NOT Include Additional Discounts

Pursuant to the Bipartisan Budget Act of 2015, manufacturers participating in the Medicaid Drug Rebate Program must pay an Additional Discount on Non-Innovator products to the extent the Average Manufacturer Prices (“AMPs”) of their products are rising faster than inflation when compared to a base line period. However, the Centers for Medicare & Medicaid Services (“CMS”) stated in April 14, 2017 e-mail correspondence to manufacturer technical contacts listed for the Drug Data Reporting for Medicaid System (“DDR”) that DDR system updates needed to automate the Additional Discount calculation on Non-Innovator products were not finalized in time and, as such, first quarter 2017 Unit Rebate Amounts for Non-Innovator products will NOT include the calculated Additional Discount, if any.

Continue Reading →
E-Health, False Claims Act, Telemedicine & E-health
alert
Not Just for Health Care Providers Anymore: Health IT Vendor Pays $155 Million to Settle False Claims Act Case
Last week, eClinicalWorks (ECW)—an electronic health records (EHR) vendor—settled an intervened False Claims Act case with the Department of Justice for $155 million. This novel FCA settlement illustrates that health care fraud prosecution extends far beyond just the health care providers and payors that directly submit claims to Medicare, Medicaid and other federal health care programs, and can extend liability to subcontractors, agents, and vendors.
 

EHR Tech Must Meet “Meaningful Use” Standards

Continue Reading →

SUBSCRIBE

Add the Arent Fox Health Care Law blog to your RSS feed reader.

Arent Fox In Your Inbox
To subscribe to Arent Fox Alerts and other news, click here.

ABOUT ARENT FOX LLP

Arent Fox LLP, founded in 1942, is internationally recognized in core practice areas where business and government intersect. With more than 350 lawyers, the firm provides strategic legal counsel and multidisciplinary solutions to clients that range from Fortune 500 corporations to trade associations. The firm has offices in Los Angeles, New York, San Francisco, and Washington, DC.